Rexahn Pharmaceuticals, Inc. (RNN) was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the past one month’s volatile price range of $0.70 to $0.83.
This clinical stage biopharmaceutical company has witnessed one positive estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same time frame. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
Rexahn Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors looking for well-positioned stocks in the Med-Biomed/Generic industry may consider Cambrex Corporation. (CBM), Gilead Sciences Inc. (GILD) and Heska Corporation (HSKA). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment